Last update 29 Sep 2024

Hangzhou Bolin Pharmaceutical Technology Co., Ltd.

Private Company | Subsidiary Company|
2023|
Zhejiang Sheng, China

Overview

Basic Info

Introduction
Hangzhou Bolin Pharmaceutical Technology Co., Ltd was established in April 2021 by a team of scientists with extensive experience in siRNA drug development. The company is dedicated to developing a new generation of siRNA drugs to provide urgently needed and improved treatment options for patients worldwide. The Bolin Pharmaceutical team reportedly has years of professional experience in all aspects of RNAi drug development, including nucleotide sequence design, chemical modification, GalNAc delivery technology, extracellular liver targeting delivery technology, oligonucleotide synthesis, and CMC, establishing a comprehensive nucleic acid drug development platform.

Tags

Endocrinology and Metabolic Disease
Cardiovascular Diseases
Digestive System Disorders
siRNA

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Top 5 Drug TypeCount
siRNA4
Top 5 TargetCount
AGT(Angiotensinogen)1

Corporation Tree

Boost your research with our corporation tree data.
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 05 Oct 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Phase 1
3
1
Phase 2
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
BW-00112
Dyslipidemias
More
Phase 2
BW-20805
Hereditary Angioedema
More
Phase 1
BW-20507
Hepatitis B, Chronic
More
Phase 1
BW-00163
( AGT )
Hypertension
More
Phase 1
Login to view more data

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free